The Evaluation Of Renoprotective Effect Of L-Carnitine Against Gentamicin Nephrotoxicity | 23457
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 312

Clinical Pharmacology & Biopharmaceutics received 312 citations as per google scholar report

Clinical Pharmacology & Biopharmaceutics peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Euro Pub
Share This Page

The evaluation of renoprotective effect of L-Carnitine against gentamicin nephrotoxicity

2nd International Summit on Clinical Pharmacy

Sabah Akrawi

ScientificTracks Abstracts: Clinic Pharmacol Biopharm

DOI: 10.4172/2167-065X.S1.006

The protective effect of L-Carnitine on the gentamicin nephrotoxicity was investigated in experimental animal model. Male Wister 200-300 g rats were distributed randomly into four groups, control group, L-Carnitine treated group, Gentamicin treated group, and L-Carnitine + Gentamicin treated group. The result showed that gentamicin nephrotoxicity in rats is detected by significant plasma creatinine, urea and zinc changes in serum and renal tissue. L-Carnitine is able to ameliorate the renal functions and restore the zinc status. Zinc serum level in the gentamicin treated group is 115 μg/dl, while it is 129 μg/ dl in the Gentamicin + L-Carnitine treated group, and Zinc tissue level in the Gentamicin treated group is 14.6 μg/dl, while it is 17.89 μg/dl in the Gentamicin + L-Carnitine treated group. The possibility of scavenging property of L-Carnitine against peroxy radical is via restoring zinc status implicated.
Sabah Akrawi, PhD, graduated from the College of Pharmacy/University of Kentucky/USA. He is an Assoc. Prof. of Clinical Pharmacokinetic and Biopharmaceutic and a faculty member at the College of Clinical Pharmacy/King Faisal University/KSA. He supervised 17 postgraduate pharmacy students, and has published more than 24 articles. He is a member of the scientific council of the KFU and chaired many defense committees for graduation of graduate students.